DG Gel 8 Card

Device Grifols Diagnostic Solutions, Inc.
Total Payments
$36,245
Transactions
9
Doctors
8
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2019 $252.72 8 8
2018 $35,992 1 0

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $35,992 1 99.3%
Food and Beverage $252.72 8 0.7%

Payments by Type

Research
$35,992
1 transactions
General
$252.72
8 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
In Vitro Diagnostic Study to Qualify the Anti-D IgM plus IgG Blood Grouping Reagent IgM clones P3x61 and P3x21223 B10 and IgG clones P3x290 and P3x35 for use in the DG Gel 8 Card Diagnostic Grifols Diagnostic Solutions, Inc. $35,992 0

Top Doctors Receiving Payments for DG Gel 8 Card

Doctor Specialty Location Total Records
Unknown Albuquerque, NM $35,992 1
, MD Anatomic Pathology & Clinical Pathology San Francisco, CA $31.59 1
, MD Blood Banking & Transfusion Medicine Denver, CO $31.59 1
, MD Internal Medicine Boston, MA $31.59 1
, D.O Blood Banking & Transfusion Medicine Lewisburg, WV $31.59 1
, M.D Clinical Pathology/Laboratory Medicine New York, NY $31.59 1
, MD Clinical Pathology Winston Salem, NC $31.59 1
, MD Anatomic Pathology & Clinical Pathology Oklahoma City, OK $31.59 1
, MD Anatomic Pathology & Clinical Pathology Denver, CO $31.59 1

About DG Gel 8 Card

DG Gel 8 Card is a device associated with $36,245 in payments to 8 healthcare providers, recorded across 9 transactions in the CMS Open Payments database. The primary manufacturer is Grifols Diagnostic Solutions, Inc..

Payment data is available from 2018 to 2019. In 2019, $252.72 was paid across 8 transactions to 8 doctors.

The most common payment nature for DG Gel 8 Card is "Unspecified" ($35,992, 99.3% of total).

DG Gel 8 Card is associated with 1 research study, including "In Vitro Diagnostic Study to Qualify the Anti-D IgM plus IgG Blood Grouping Reagent IgM clones P3x61 and P3x21223 B10 and IgG clones P3x290 and P3x35 for use in the DG Gel 8 Card Diagnostic" ($35,992).